OM 40 + OM/HCTZ 40/12.5

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Hypertension

Conditions

Hypertension

Trial Timeline

Jul 1, 2007 → May 1, 2008

NCT ID

NCT00441350

About OM 40 + OM/HCTZ 40/12.5

OM 40 + OM/HCTZ 40/12.5 is a phase 3 stage product being developed by Daiichi Sankyo for Hypertension. The current trial status is completed. This product is registered under clinical trial identifier NCT00441350. Target conditions include Hypertension.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00441350	Phase 3	Completed	Jul 1, 2007	May 1, 2008	Hypertension

Competing Products

20 competing products in Hypertension

See all competitors

Product	Company	Stage	Hype Score
macitentan 10 mg	BML, Inc.	Phase 3	76
tadalafil + tadalafil	Eli Lilly	Phase 3	77
CS1 Administration	Cereno Scientific	Phase 2	47
CS1	Cereno Scientific	Pre-clinical	18
TX000045- Dose A + TX000045- Dose B + Placebo	Tectonic Therapeutic	Phase 2	44
Dose A KER-012 + Dose B KER-012 + Dose C KER-012 + Placebo for 24 Weeks followed by Dose B KER-012 for 72 weeks	Keros Therapeutics	Phase 2	44
Tirzepatide + Tirzepatide Placebo	Eli Lilly	Approved	85
L04RD1 + L04TD3	Celltrion	Phase 1	33
Azilsartan Medoxomil	Celltrion	Pre-clinical	23
AZM X mg + AML Y mg + AZM X mg + AML Y' mg + AZM X' mg + AML Y mg + AZM X' mg + AML Y' mg + AZM X mg + AZM X' mg + AML Y mg + AML Y' mg	Celltrion	Phase 3	77
Satralizumab (Genetical Recombination)	Chugai Pharmaceutical	Phase 2	52
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg	Yuhan	Approved	85
Telmisartan + Amlodipine + Chlorthalidone	Yuhan	Phase 1	33
Temisartan/Amlodipine+Rosuvastatin + YHP1604	Yuhan	Phase 1	33
Temisartan+Amlodipine+Rosuvastatin (Combination drug) + Temisartan+Amlodipine + Temisartan+Rosuvastatin	Yuhan	Phase 3	77
Amlodipine + Valsartan	Yuhan	Approved	85
Duowell® + Telmisartan	Yuhan	Approved	85
YHP1701 + YHR1703 + YHR1704	Yuhan	Phase 3	77
YH22189 + Twynsta 80/10mg + Crestor 20mg	Yuhan	Phase 1	33
Rosuvastatin+Valsartan (Sequence 1) + Rosuvastatin+Valsartan (Sequence 2) + Rosuvastatin+Valsartan (Sequence 3) + Rosuvastatin+Valsartan (Sequence 4) + Rosuvastatin+Valsartan (Sequence 5) + Rosuvastatin+Valsartan (Sequence 6)	Yuhan	Phase 1	33

Other Products from Daiichi Sankyo

Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide + HydrochlorothiazideApproved

OAC aloneApproved

olmesartan medoxomil + Placebo + losartan potassiumApproved

Prasugrel + ClopidogrelApproved

Diet+pravastatinApproved